Literature DB >> 17214403

Low-intensity exercise, vascular occlusion, and muscular adaptations.

Masaru Teramoto1, Lawrence A Golding.   

Abstract

The study investigated the effects of low-intensity exercise on muscular fitness when combined with vascular occlusion. Nineteen college male and female students performed two sets of a 5-min step exercise using a 12-inch bench three times per week for 5 weeks. During the step exercise, blood flow to one leg was restricted (vascular occlusion) with a blood pressure cuff, while the other leg was not occluded. Muscular strength of the occluded leg was significantly increased over the nonoccluded leg (p < 0. 05). Muscular endurance and muscle mass were improved after 5 weeks of training (p < 0.05); however, the changes between the two legs were not significantly different (p > 0.05). Exercise with vascular occlusion has the potential to be an alternative form of training to promote muscular strength.

Entities:  

Mesh:

Year:  2006        PMID: 17214403     DOI: 10.1080/15438620600985860

Source DB:  PubMed          Journal:  Res Sports Med        ISSN: 1543-8627            Impact factor:   4.674


  3 in total

1.  Effects of cuff width on arterial occlusion: implications for blood flow restricted exercise.

Authors:  Jeremy P Loenneke; Christopher A Fahs; Lindy M Rossow; Vanessa D Sherk; Robert S Thiebaud; Takashi Abe; Debra A Bemben; Michael G Bemben
Journal:  Eur J Appl Physiol       Date:  2011-12-06       Impact factor: 3.078

2.  Utilization of Vascular Restriction Training in post-surgical knee rehabilitation: a case report and introduction to an under-reported training technique.

Authors:  Peter M Lejkowski; Jason A Pajaczkowski
Journal:  J Can Chiropr Assoc       Date:  2011-12

3.  Effectiveness of blood flow restricted exercise compared with standard exercise in patients with recurrent low back pain: study protocol for a randomized controlled trial.

Authors:  Shinichi Amano; Arimi Fitri Mat Ludin; Rachel Clift; Masato Nakazawa; Timothy D Law; Laura J Rush; Todd M Manini; James S Thomas; David W Russ; Brian C Clark
Journal:  Trials       Date:  2016-02-12       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.